Without anti-CD40 treatment, the pulmonary disease outcome after MC38 spheroid injection was not different in WT and Keap1flox/flox VavCre mice, suggesting that in the absence of immunomodulatory interventions, immunosurveillance does not significantly change tumor fate within the short observation period. The gene discussed is CD40; the disease is lung disorder.